Mirum Pharmaceuticals's total assets for Q1 2025 were $690.25M, an increase of 2.91% from the previous quarter. MIRM total liabilities were $456.99M for the fiscal quarter, a 2.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.